Lenz & Staehelin advised Hasten in this transaction. Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss...
Lenz & Staehelin advised Hasten in this transaction. Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss...